Non–Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement


Suresh S. Ramalingam, MD, on Managing Pyrexia With Dabrafenib/Trametinib in Advanced NSCLC

Posted: Monday, June 10, 2019

What is your protocol when a patient with advanced NSCLC who is receiving dabrafenib/trametinib develops a grade 1 or 2 fever or higher?